Yeast exo-β-1,3-glucanase (EXG1) was evaluated as an inhibitory agent of Colletotrichum lupini and Botrytis cinerea. Extracts obtained from yeast transformed with the exg1 gene, expressing high levels of EXG1 activity, or control untransformed yeast cultures that lacked EXG1 activity, were added to different starting concentrations of C. lupini fungal spore suspensions (2.5 × 10 3 to 80 × 10 3 spores per flask), and mycelial dry weight was measured after 5 days. Inhibition of C. lupini mycelial growth by EXG1 compared with control extracts ranged from 41 to 20% when added to starting fungal spore concentrations of 2.5 × 10 3 to 80 × 10 3 , respectively. EXG1 activity in the extracts from the transformed yeast remained high over the 5-day incubation period. Addition of the EXG1 extract after C. lupini spore germination resulted in lower inhibition, indicating that the EXG1 targets the β-glucan in the cell walls of the fungal spores at an early stage of germination. Furthermore, the yeast EXG1 extracts were also shown to inhibit Botrytis cinerea spore germination and growth. Thus, the use of the yeast exg1 gene for protection of crops, such as lupin and pear in transgenic strategies against C. lupini and B. cinerea, respectively, could be considered.
Introduction
Anthracnose is considered as the most devastating fungal disease for lupin producers worldwide (Koch et al., 2002) as it can cause crop losses of up to 100%. Colletotrichum lupini causes this disease in Southern Africa (Lotter and Berger, 2005) . Lupin anthracnose therefore, represents a major threat to the South African lupin industry, which has an annual turnover of approximately 60 million rands [personal communication: Dr M Griessel, Protein Research Foundation (PRF) , Rivonia, South Africa, 2003 ]. In turn, Botrytis cinerea is one of the most commonly found fungal pathogens and causes significant postharvest losses of deciduous fruit, including pear (Lennox et al., 2003) , following initial infection by means of spores in the orchard.
It is well documented that plants activate a number of inducible and active defence responses following elicitor treatment or microbial attack (Broglie et al., 1986; Lawton and Lamb, 1987; Lamb et al., 1989; Vigers et al., 1991; Keen, 1992; Latunde-Dada and Lucas, 2001 ), e.g. pathogenesis-related (PR) proteins, such as β-endoglucanases and chitinases (Ham et al., 1991; Stinzi et al., 1993) . Several β-1,3-endoglucanase genes from plants (E.C. 3.2.1.39) have been cloned with the aim to use them for transgenic fungal resistance (Edington et al., 1991; Chang et al., 1993) . Transgenic tobacco plants expressing an acidic β-1,3-glucanase from alfalfa were reported to be resistant to Cercospora nicotianae (Zhu et al., 1994) and transgenic tomato resistant to Fusarium wilt was produced by transformation with a class I basic β-1,3-glucanase from tobacco (Van den Elzen et al., 1993) . Transgenic tobacco plants over-expressing ß-1,3-glucanase showed enhanced resistance against certain fungal pathogens (Yoshikawa et al., 1993) . Schlumbaum et al. (1986) showed that physiological concentrations of β-1,3-glucanase inhibited the growth of many pathogenic fungi.
Beta-(1,3)-exoglucanases (E.C. 3.2.1.5.8) have also been reported as inhibiting agents of fungal growth. A secretory β-1,3-exoglucanase of Aspergillus oryzae, was found to play a role in β-glucan utilization and an application in plant defence was suggested (Tamano et al., 2007) . In addition, the Trichoderma harzianum AGN13.1 enzyme, an (1,3)-exoglucanase purified from culture filtrates, was highly specific for α-1,3-linkages in polysaccharides (Ait-Lahsen et al., 2001) . Different rates of spore germination and inhibition were observed by the addition of the AGN13.1 enzyme to cultures of Aspergillus niger, B. cinerea and Penicillium aurantiogriseum, and it was suggested that the expression of the agn13.1 gene in transgenic plants could lead to the production of plants with improved resistance to fungal pathogens. A patent for the use of an exoglucanase from Coniothyrium minitrans for the improved resistance of plants against phytopathogens has also been registered (Frick et al., 2001) .
Saccharomyces cerevisiae has a complex system of glucanases, encompassing several forms that are classified as exo-and endo-glucanases (Van Rensburg et al., 1997) . Some of these glucanases are capable of hydrolysing β-O-glycosidic linkages of β-glucan chains, leading to the release of glucose and oligosaccharides. The exoglucanases yield glucose as the end product of β-glucan hydrolysis. The endoglucanases attack the linkages at intermediate points of the polymer chain, releasing a mixture of oligosaccharides and glucose as a minor product (Larriba et al., 1995) . During the vegetative growth of yeast, several endo-and exo-β-1,3-glucanases are synthesized, some of which are secreted and remain in the cell wall, with others being released into the surrounding medium. Yeast cells possess a predominantly β-1,6-linked polymer that contains only a few β-1,3-linkages. Thus, it is believed that yeast exoglucanases are involved in the morphogenic processes involved in controlled autolysis of β-1,3-glucan, including cell wall metabolism. Other processes that are also thought to be dependent on the actions of glucanases are apical growth, branching and budding, mating and the formation and release of ascospores. Three exoglucanase (Exg) genes have been reported in S. cerevisiae (Larriba et al., 1995) . The Exg1 gene encodes for the major isozyme [yeast exo-β-1,3-glucanase (EXG1)] that is expressed during vegetative growth (Muthukumar et al., 1993) . The other two genes have been designated Exg2 and Ssg1 (Larriba et al., 1995) , the latter gene being synthesized only during sporulation of S. cerevisiae diploids (Muthukumar et al., 1993) . The exg1 gene from S. cerevisiae has been cloned and over-expressed in yeast (Van Rensburg et al., 1997 (Nebreda et al., 1986) . The yeast exg1 gene was shown to completely inhibit the growth of a B. cinerea isolate from grapevine when exposed to a culture filtrate obtained from a yeast culture over-expressing the enzyme (Pretorius, personal communication; Lampbrechts et al., 1997) . Cultures of the control yeast strain had no effect on the growth of the fungus. For this reason, it was proposed to investigate the potential use of the exg1 gene for genetic modification of crop species for resistance to fungi, such as C. lupini and B. cinerea. In this report, the possible use of the yeast exg1 gene for protection of crops, such as lupin and pear, in transgenic strategies against C. lupini and B. cinerea, respectively, is evaluated.
Materials and Methods
Yeast culture transformed with the exg1 gene Exg1 transformed and untransformed S. cerevisiae Y294 (Van Rensburg et al., 1997) cultures were obtained from the Institute for Wine Biotechnology, University of Stellenbosch, South Africa. The exg1 gene was isolated from S. cerevisiae total genomic DNA and cloned into the Escherichia coli-S. cerevisiae shuttle plasmid YEp24 (designated pBG1), and following recombinant plasmid DNA isolation, was used to transform S. cerevisiae Y294 to produce Y294 (Ura + ). The exg1 gene fragment contained the exg1 gene with its native promoter and terminator sequences.
Growth curves and determination of exo-glucanase activity of exg1 transformed and untransformed yeast cells A 10-ml yeast peptone dextrose (YPD) culture medium containing 10 μl of 100 mg/ml ampicillin stock (Amp 100 ) was either inoculated with 5 μl of the exg1 transformed yeast or 5 μl of the untransformed yeast. These were incubated overnight at 30°C with gentle shaking. The following day, 24 × 100 ml YPD cultures (Amp 100 ) were inoculated with either 50 μl of the exg1 transformed or 50 μl of the untransformed yeast overnight YPD cultures and incubated at 30°C with gentle shaking. At each of the designated time points, 0, 12, 16, 20, 24, 32, 48 and 72 h after inoculation, three of the exg1 transformed and three of the untransformed yeast cultures were harvested. Harvesting was performed by first obtaining the OD 650 values and then removing the yeast cells by centrifugation for 5 min at 5000 g at 4°C. The supernatants were filter sterilized before being stored in sterile containers at 4°C. Growth curves for the exg1 transformed and untransformed yeast cells were constructed by using the recorded optical density (OD 650 ) values.
Glucanase activity was determined for both the exg1 transformed and untransformed yeast cells at each of the time points used for the construction of the growth curves, and for the pre-and postammonium sulphate fractions when the extracts were prepared for the inhibition studies. The assay was performed over a 60-min time period with glucanase activity being determined at t 0 and t 60 min. Glucanase assays were performed on the 20 h exg1 transformed and untransformed yeast culture filtrates when performing the inhibition studies. Enzyme activity readings, three replicates per culture filtrate, were taken at t 0 and t 60 . For the glucanase assay, 780 μl of culture filtrate was added to 20 μl 2 mMp-nitrophenyl-glucoside and 200 μl 0.05 M sodium citrate (pH 4.8). The reaction was incubated at 37°C, and at each time point, 250 μl of the reaction mix was added to 500 μl 1 M sodium carbonate to stop the reaction. These were placed on ice until the end of the assay period, after which the A 405 values were obtained.
Preparation of Colletotrichum lupini and Botrytis cinerea fungal spores for inhibition studies
The C. lupini var. setosum [isolate SHK 788 from Lupinus albus plants (Lotter and Berger, 2005) ] and B. cinerea (from pear) [SH Koch, ARC-Plant Protection Research Institute (ARC-PPRI), Pretoria, South Africa] were grown on 10 ml potato dextrose agar slants in wide neck 26 ml McCartney bottles for 10 days under 12 h fluctuating light/darkness regimes at 23°C. Five millilitres sterile distilled water were added to each fungal culture. Spores in the cultures were dislodged with a glass rod of which the one point was curved with a 45° angle. Spore suspensions were filtered through a double layer of cheesecloth. The concentration of the spore suspension was determined with a haemocytometer. The concentration of the spore suspension was adjusted to 4 × 10 4 condia/ml. This suspension was further diluted aseptically to 2 × 10 4 , 1 × 10 4 , 0.5 × 10 4 and 0.25 × 10 4 spores/ml. Botrytis cinerea spore suspensions were also prepared using this protocol.
Growth inhibition assay with exo-glucanase filtrates
Fifty 1-l Erlenmeyer flasks containing 50 ml 2% malt extract (Sigma) were prepared and autoclaved at 121°C for 30 min. Under sterile conditions, 25 of these flasks were inoculated with either 25 ml of the filter-sterilized filtrate obtained from the exg1 transformed yeast cultures or with 25 ml of the filter-sterilized filtrate obtained from the untransformed yeast cultures. To each flask, 50 μl Amp (100 mg/ml stock) was added to prevent bacterial contamination of the cultures. The flasks were inoculated, in triplicate, with 1 ml of the various spore concentration suspensions used: 0, 2.5 × 10 3 , 5 × 10 3 , 10 × 10 3 , 20 × 10 3 , 40 × 10 3 , 60 × 10 3 and 80 × 10 3 spores/ml. The flasks were incubated at room temperature (±23°C) for 5 days on a laboratory bench before harvesting. Each sample was filtered through a Whatman No. 1 filter paper disc using a Buchner funnel and suction filtration. Filtrates were discarded. Filter paper discs containing the mycelia were dried overnight at 67°C and the weight recorded in grams. The dry weights at each spore concentration to which the untransformed culture filtrate was added (control flasks) were set to 100%. Inhibition of C. lupini and B. cinerea growth at each spore concentration was calculated in relation to the growth in the control flask of that specific spore concentration. The percentage inhibition of fungal growth by the exg1 transformed yeast extract was calculated as follows:
An 80% ammonium sulphate precipitation step was performed on the culture filtrates of the exg1 transformed and untransformed yeast cultures. A 10-ml aliquot of the exg1 transformed yeast and untransformed yeast filtrate was kept at 4°C for determination of preammonium sulphate glucanase activity at a later stage. Culture filtrates (100 ml) were adjusted to 80% saturation with the addition of powdered ammonium sulphate. The samples were maintained at 4°C at all times and left overnight with gentle shaking. Samples were, subsequently, centrifuged at 10 000 g for 30 min at 4°C. The precipitates were resuspended in 25 ml 0.05 M sodium citrate (pH 4.8), centrifuged and the supernatants filter sterilized.
Results
Growth curves and glucanase activity of exg1 transformed and untransformed yeast A comparative analysis of the growth curves for the exg1 transformed and untransformed yeast cells was performed. The growth of the exg1 transformed yeast cells plateaued at 20 h after inoculation and grew to higher cell densities than untransformed, while the growth of the untransformed yeast cells plateaued at 24 h after inoculation (data not shown). Glucanase activity assays were performed to determine at which time point the maximum glucanase activity occurred in the exg1 transformed yeast cell cultures to be used for the C. lupini and B. cinerea spore inhibition studies by the glucanase enzyme.
Glucanase activity was present in the filtrates of the exg1 transformed yeast cells and at much lower activity in the filtrates of the untransformed yeast cells (Fig. 1) . Highest glucanase activity for the exg1 transformed yeast cells was measured at 20 h after inoculation, which corresponded to the plateau reached in growth observed for the exg1 transformed yeast cells at 20 h after inoculation. All further experiments were performed by growing of the yeast cultures for 20 h before harvesting of the cultures. 
Inhibition of Colletotrichum lupini and Botrytis cinerea mycelial growth by glucanase filtrates
The untransformed yeast culture filtrate showed extremely low glucanase activity (ΔA 405 = 0.005), while the exg1 transformed yeast culture filtrate had high glucanase activity (ΔA 405 = 0.108). Two days after inoculation, all cultures exhibited germination of the spores at all levels of spore concentrations. The C. lupini and B. cinerea mycelial dry weights were determined 5 days after inoculation (Table 1) . At all spore concentrations, C. lupini mycelial growth was higher in the flasks inoculated with the untransformed yeast extract (controls) than in the flasks inoculated with the exg1 transformed yeast extracts, i.e. extracts containing the glucanase enzyme (Table 1 ). The contents of the flasks were assayed for EXG1 activity at days 1, 3 and 5 after inoculation, and results showed that enzyme activity was retained (data not shown). The percentage inhibition of fungal growth (Table 2) was calculated for each spore concentration by subtracting the mycelial growth at day 5 for the spores exposed to the EXG1 extract from the growth of the same amount of spores mixed with the control extract (calculated from data in Table 1 ). The percentage inhibition of C. lupini mycelial growth by the constant amount of glucanase enzyme (unconcentrated extract) increased with a decrease in the amount of fungal spores added to the starting inoculum, i.e. from 19% for 80 × 10 3 spores inoculated to 41% for 2.5 × 10 3 spores of C. lupini (Table 2 , column 2). In a repeat experiment, the percentage inhibition of C. lupini mycelial growth by the constant amount of glucanase enzyme (unconcentrated extract) increased with a decrease in the amount of fungal spores added to the starting inoculum, i.e. from 20% for 80 × 10 3 spores inoculated to 38% for 5 × 10 3 spores of C. lupini (Table 2 , column 3).
The glucanase assay results of the pre-and postammonium sulphate fractions showed a 2.5-fold increase in the glucanase activity after ammonium sulphate precipitation of the crude culture filtrate of the exg1 transformed yeast cells (data not shown). However, in a third experiment, the ammonium sulphate concentrated extract yielded similar results, with the inhibition ranging from 20% for 40 × 10 3 spores inoculated to 41% for 2.5 × 10 3 spores of C. lupini (Table 2 , column 4).
A fourth experiment was performed using the C. lupini fungal spores where the enzyme extract was added to the spores after they had germinated (Table 2 , column 5). However, inhibition of fungal mycelial growth was much lower (maximum of 15% inhibition of dry weight when added to 2.5 × 10 3 spores/ml) than when EXG1 extracts were added prior to germination.
Discussion
Results indicated that the percentage inhibition of C. lupini mycelial growth by a constant amount of unconcentrated glucanase enzyme extract remained constant (Table 2, column 2 and Table 2 , column 3: from 19% for 80 × 10 3 spores inoculated to 41% for 2.5 × 10 3 spores inoculated and from 20% for 80 × 10 3 spores inoculated to 38% for 5 × 10 3 spores inoculated, respectively). The proposed reason for these results is that the glucanase enzyme will attack the β-glucan-containing fungal spores and developing mycelia, killing off some of the developing fungal material, resulting in the reduction of mycelial growth. At the lowest spore concentrations (5 × 10 3 spores/ml), growth inhibition by EXG1 was substantial (38%).
Furthermore, the ammonium sulphate-concentrated glucanase enzyme extract yielded similar results with no increase in percentage inhibition being observed despite a more concentrated enzyme extract being added to the fungal spore suspensions (Table 2 , column 3: from 20% for 40 × 10 3 spores inoculated to 41% for 2.5 × 10 3 spores inoculated). Table 2 shows that the glucanase exerts its greatest effect on the fungal spores or at the early stage of germination, and following germination, the glucanase is less effective in attacking the mycelia. Lampbrechts et al. (1997) reported 100% growth inhibition of a grapevine isolate of B. cinerea by exg1 transformed yeast extracts. An experiment to find the effect of the glucanase enzyme on B. cinerea spore germination and mycelial growth was thus performed in order to investigate whether similar results could be obtained. The B. cinerea study yielded similar results to those obtained for the C. lupini inhibition studies. As observed for C. lupini, at all spore concentrations, B. cinerea mycelial growth was higher in the flasks inoculated with the untransformed yeast extract than in the flasks inoculated with the exg1 transformed yeast extracts, i.e. extracts containing the glucanase enzyme (Table 1 ). The percentage inhibition of B. cinerea mycelial growth by the constant amount of glucanase enzyme increased with a decrease in the amount of fungal spores added to the starting inoculum, i.e. from 19% for 40 × 10 3 spores inoculated to 32% for 2.5 × 10 3 spores of B. cinerea (calculated from data in Table 1 ). These results are similar to those obtained for the inhibition of C. lupini mycelial growth by exg1 transformed yeast culture filtrate (Table 1) when similar concentrations of the enzyme was added to the spores. Results obtained in this study with B. cinerea did not correlate with the data of Pretorius (personal communication) and Lampbrechts et al. (1997) , who found 100% inhibition of B. cinerea growth by exg1 yeast extracts. This may be attributed to the differences in the properties of the fungal isolates, as the B. cinerea isolate used in this study was from pear, whereas the B. cinerea isolate used by Van Rensburg et al. (1997) was from grape.
Certain fungi that are sensitive to ß-1,3-glucanases and chitinases become resistant to these enzymes after several hours of exposure to these enzymes (Ludwig and Boller, 1990) . This is an indication that the fungi are able to adapt to the presence of these enzymes. A similar phenomenon could have been observed in this study. The EXG1 extract was added to the fungal spores and left to incubate for 5 days, during which enzyme activity was still retained, and could have resulted in sufficient time for the fungus to adapt to the presence of the enzyme.
Another possible explanation for the levels of inhibition obtained in this study not exceeding 41% could be that the fungus secreted an inhibitor of the EXG1. It is known that fungi can secrete proteins that have the ability to inhibit the action of plant enzymes, such as the ß-1,3-glucanases (Ham et al., 1997) . For biotechnological applications, it is of great importance to determine whether the target pathogen produces an inhibitor of the proposed antifungal protein to be expressed in the transgenic plant.
It can be concluded from the presented data that exposure of fungal spores of C. lupini and B. cinerea to yeast exo-glucanase results in the inhibition of spore germination and mycelial growth. Expression of the yeast exg1 gene in transgenic plants at the site of spore germination of pathogenic fungi, such as C. lupini and B. cinerea, for example, the leaf surfaces of lupin plants or the immature flowers or skin of pear fruit; has promise as a biotechnological tool for enhanced protection of crop plants against phytopathogenic fungi.
